Evidence Hub

Stability-Indicating HPLC for Remogliflozin, Vildagliptin, and Metformin: Method Development, Validation, and Greenness

Himani Acharya, R. Kotadiya

Annales Pharmaceutiques Françaises, 2024

4 citations

Abstract

OBJECTIVE

The present work represents a reverse-phase high-performance liquid chromatography method in addition to stability studies for sequential estimation of Remogliflozin Etabonate, Vildagliptin, and Metformin HCl in tablet formulation.

METHOD

The mentioned method utilizes a Phenomenex Luna C18 column (250 × 4.6 mm, 5 μm). It consists of a column oven's temperature of 35 ͦ C. Mobile phase includes a mixture of 50% Phosphate buffer (pH - 6.8) and 50% Acetonitrile along with a flow rate of 0.8 mL/min and 20 minutes of run time. The injection volume was 20 μL. 217 nm is a detection wavelength, and a PDA detector is used for detection.

RESULTS

The suggested technique was proven and validated per the ICH Q2(R1) guideline. The combination was put under stress conditions that included acid, base, thermal, photolytic, and oxidative degradation. The combination was considerably degraded under oxidative, acidic, and basic circumstances for deterioration, and the degradation results were accurately identified from the observed peaks, demonstrating the method's effectiveness in detecting stability.

CONCLUSION

The technique was quick, precise, sensitive, and accurate; as a result, it may be used in quality control laboratories and the pharmaceutical industry for routine quality monitoring of tablets containing all three medications.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free